{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:24:29Z","timestamp":1763018669208,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.gore.2024.101357","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T11:50:24Z","timestamp":1709207424000},"page":"101357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Successful fertility preservation in stage II endometrial carcinoma with long-term progestin therapy: A case report"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7635-3028","authenticated-orcid":false,"given":"Yuki","family":"Kashihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sekiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitoshi","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2024.101357_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine neoplasms, version 1.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.gore.2024.101357_b0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.gore.2024.101357_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2024.101357_b0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","article-title":"Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: a systematic review and meta-analysis","volume":"273","author":"De Rocco","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.gore.2024.101357_b0025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3892\/ol.2012.602","article-title":"Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma","volume":"3","author":"Fujiwara","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.gore.2024.101357_b0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101357_b0035","first-page":"1023","article-title":"Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma","volume":"29","author":"Kashima","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.gore.2024.101357_b0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2012.12.037","article-title":"Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin","volume":"129","author":"Park","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101357_b0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/aogs.12570","article-title":"Contrast-enhanced MRI in preoperative assessment of myometrial and cervical invasion, and lymph node metastasis: diagnostic value and error analysis in endometrial carcinoma","volume":"94","author":"Teng","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.gore.2024.101357_b0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3802\/jgo.2009.20.2.67","article-title":"Current status of gynecologic cancer in Japan","volume":"20","author":"Ushijima","year":"2009","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101357_b0055","unstructured":"Vital Statistics of Japan, 2019. The Ministry of Health, Labor, and Welfare, https:\/\/www.mhlw.go.jp\/english\/database\/db-hw\/dl\/81-1a2en.pdf (accessed 22 February 2024)."},{"key":"10.1016\/j.gore.2024.101357_b0060","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.3802\/jgo.2020.31.e18","article-title":"Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms","volume":"31","author":"Yamagami","year":"2020","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.gore.2024.101357_b0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00280-017-3342-5","article-title":"Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer","volume":"80","author":"Yunokawa","year":"2017","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:59:23Z","timestamp":1762480763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":13,"alternative-id":["S2352578924000365"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101357","relation":{},"ISSN":["2352-5789"],"issn-type":[{"type":"print","value":"2352-5789"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful fertility preservation in stage II endometrial carcinoma with long-term progestin therapy: A case report","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101357"}}